Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,842 | -17,419 | -7,215 | -23,463 | -16,213 |
| Depreciation Amortization | 17 | 41 | 29 | 14 | 2 |
| Accounts payable and accrued liabilities | 228 | -112 | 179 | 750 | 1,589 |
| Other Working Capital | -856 | -2,315 | -2,701 | 673 | 1,774 |
| Other Operating Activity | 1,324 | 1,022 | 181 | 149 | -987 |
| Operating Cash Flow | $-29,129 | $-18,783 | $-9,527 | $-21,877 | $-13,835 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,911 | -27,629 | 4,772 | -23,920 | -21,808 |
| PPE Investments | -22 | -22 | -15 | -140 | -140 |
| Investing Cash Flow | $-37,933 | $-27,651 | $4,757 | $-24,060 | $-21,948 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,852 | 80,645 | 69,406 | N/A | N/A |
| Other Financing Activity | 15,432 | 15,504 | 17,150 | 43,579 | 45,575 |
| Financing Cash Flow | $96,284 | $96,149 | $86,556 | $43,579 | $45,575 |
| Beginning Cash Position | 5,024 | 5,024 | 5,024 | 7,382 | 7,382 |
| End Cash Position | 34,246 | 54,739 | 86,810 | 5,024 | 17,174 |
| Net Cash Flow | $29,222 | $49,715 | $81,786 | $-2,358 | $9,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,129 | -18,783 | -9,527 | -21,877 | -13,835 |
| Capital Expenditure | -22 | -22 | -15 | -140 | -140 |
| Free Cash Flow | -29,151 | -18,805 | -9,542 | -22,017 | -13,975 |